BPE-66429-64711
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 010 / MA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AJ2-11998-85152
Child or adolescent in my care · Female · 2022-02-05
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness · Fever · Fatigue or tirednessAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Chills, Headache, Muscle or body achesAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Menstrual disorder — Feeling: Good · Site: Pain · HeadacheFree text: After my first shot my menstrual period started a week early. After speaking to friends and family they have also had this happen after their first shot. I had a feeling it might be related but didnt have a chance to report it when I got my first shot. My cycle started 3 days after my shot and a week early which never happens for me.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-05
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Breast cancer, Breast discharge, Intraductal proliferative breast lesion, Lobular breast carcinoma in situ — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Revived second shot on 4/24. On 5/5 began experience ing nipple discharge. Had mri and biopsies on both breasts. One breast is LCIS. The other is DCIS cancer.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-12
- 2021-10-24
-
2022-04-26
Survey response — 12 months, dose 2MedDRA: Breast cancer, Breast reconstruction — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Exchange surgery for breast reconstruction due to cancer.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): After my first shot my menstrual period started a week early. After speaking to friends and family they have also had this happen after their first shot. I had a feeling it might be related but didnt have a chance to report it when I got my first shot. My cycle started 3 days after my shot and a week early which never happens for me.
Release 9 — 3 months, dose 2
Symptoms: Revived second shot on 4/24. On 5/5 began experience ing nipple discharge. Had mri and biopsies on both breasts. One breast is LCIS. The other is DCIS cancer.
Release 11 — 12 months, dose 2
Symptoms: Exchange surgery for breast reconstruction due to cancer.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Biopsy brain abnormal | ○ | · | ○ |
| SD | Breast cancer | ✓ | · | ✓ |
| SD | Breast discharge | ✓ | · | ✓ |
| SD | Breast reconstruction | · | · | ✓ |
| SD | Intraductal proliferative breast lesion | ✓ | · | ✓ |
| SD | Lobular breast carcinoma in situ | ✓ | · | ✓ |
| SD | Magnetic resonance imaging abnormal | ○ | · | ○ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release